| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 7.996.792 $ | 98,17 | 88.071 | |||||||
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 724.315 $ | 8,89 | 775 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 384.946 $ | 4,73 | 2.029 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 346.333 $ | 4,25 | 2.647 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 259.501 $ | 3,19 | 1.129 | |
| Nektar Therapeutics | Nektar Therapeutics | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 258.352 $ | 3,17 | 3.038 | |
| Natera Inc | Natera Inc | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 237.290 $ | 2,91 | 1.151 | |
| Tarsus Pharmaceuticals Inc | Tarsus Pharmaceuticals Inc | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 230.395 $ | 2,83 | 3.622 | |
| Guardant Health Inc | Guardant Health Inc | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 214.130 $ | 2,63 | 2.459 | |
| Argenx SE | Argenx SE | EC | NL0010832176 | Long | Modellwert (Stufe 2) | 208.603 $ | 2,56 | 266 | |
| Novartis AG | Novartis AG | EC | CH0012005267 | Long | Modellwert (Stufe 2) | 200.403 $ | 2,46 | 1.356 | |
| CVS Health Corp | CVS Health Corp | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 193.233 $ | 2,37 | 2.320 | |
| Madrigal Pharmaceuticals Inc | Madrigal Pharmaceuticals Inc | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 181.087 $ | 2,22 | 350 | |
| Intuitive Surgical Inc | Intuitive Surgical Inc | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 179.841 $ | 2,21 | 393 | |
| Cogent Biosciences Inc | Cogent Biosciences Inc | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 178.342 $ | 2,19 | 4.983 | |
| Galderma Group AG | Galderma Group AG | EC | CH1335392721 | Long | Modellwert (Stufe 2) | 171.611 $ | 2,11 | 818 | |
| UnitedHealth Group Inc | UnitedHealth Group Inc | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 170.791 $ | 2,10 | 461 | |
| Celcuity Inc | Celcuity Inc | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 163.701 $ | 2,01 | 1.349 | |
| Bridgebio Pharma Inc | Bridgebio Pharma Inc | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 161.989 $ | 1,99 | 2.278 | |
| Cencora Inc | Cencora Inc | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 161.705 $ | 1,99 | 525 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 160.107 $ | 1,97 | 698 | |
| Abivax SA | Abivax SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 152.124 $ | 1,87 | 1.296 | |
| Edwards Lifesciences Corp | Edwards Lifesciences Corp | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 148.213 $ | 1,82 | 1.775 | |
| Mirum Pharmaceuticals Inc | Mirum Pharmaceuticals Inc | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 142.754 $ | 1,75 | 1.467 | |
| UCB SA | UCB SA | EC | BE0003739530 | Long | Modellwert (Stufe 2) | 142.136 $ | 1,74 | 522 | |
| Dianthus Therapeutics Inc | Dianthus Therapeutics Inc | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 138.285 $ | 1,70 | 1.575 | |
| United Therapeutics Corp | United Therapeutics Corp | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 133.696 $ | 1,64 | 234 | |
| Vertex Pharmaceuticals Inc | Vertex Pharmaceuticals Inc | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 132.915 $ | 1,63 | 311 | |
| Thermo Fisher Scientific Inc | Thermo Fisher Scientific Inc | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 120.698 $ | 1,48 | 252 | |
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 110.108 $ | 1,35 | 764 | |
| Teva Pharmaceutical Industries Ltd | Teva Pharmaceutical Industries Ltd | EC | 881624209 | Long | Börsenkurs (Stufe 1) | 103.702 $ | 1,27 | 2.957 | |
| Adaptive Biotechnologies Corp | Adaptive Biotechnologies Corp | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 95.443 $ | 1,17 | 6.769 | |
| PTC Therapeutics Inc | PTC Therapeutics Inc | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 91.149 $ | 1,12 | 1.401 | |
| Insmed Inc | Insmed Inc | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 85.888 $ | 1,05 | 630 | |
| Mineralys Therapeutics Inc | Mineralys Therapeutics Inc | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 85.813 $ | 1,05 | 3.220 | |
| Otsuka Holdings Co Ltd | Otsuka Holdings Co Ltd | EC | JP3188220002 | Long | Modellwert (Stufe 2) | 84.689 $ | 1,04 | 1.162 | |
| CG oncology Inc | CG oncology Inc | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 81.623 $ | 1,00 | 1.223 | |
| BeOne Medicines Ltd | BeOne Medicines Ltd | EC | CH1391448177 | Long | Modellwert (Stufe 2) | 76.882 $ | 0,94 | 3.387 | |
| Rhythm Pharmaceuticals Inc | Rhythm Pharmaceuticals Inc | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 76.641 $ | 0,94 | 942 | |
| Glaukos Corp | Glaukos Corp | EC | 377322102 | Long | Börsenkurs (Stufe 1) | 75.570 $ | 0,93 | 526 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 70.688 $ | 0,87 | 962 | |
| 10X Genomics Inc | 10X Genomics Inc | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 70.560 $ | 0,87 | 3.200 | |
| HeartFlow Inc | HeartFlow Inc | EC | 42238D107 | Long | Börsenkurs (Stufe 1) | 70.234 $ | 0,86 | 2.360 | |
| Encompass Health Corp | Encompass Health Corp | EC | 29261A100 | Long | Börsenkurs (Stufe 1) | 67.700 $ | 0,83 | 677 | |
| GeneDx Holdings Corp | GeneDx Holdings Corp | EC | 81663L200 | Long | Börsenkurs (Stufe 1) | 65.783 $ | 0,81 | 1.046 | |
| TransMedics Group Inc | TransMedics Group Inc | EC | 89377M109 | Long | Börsenkurs (Stufe 1) | 65.514 $ | 0,80 | 650 | |
| DBV Technologies SA | DBV Technologies SA | EC | 23306J309 | Long | Börsenkurs (Stufe 1) | 62.433 $ | 0,77 | 2.973 | |
| Stryker Corp | Stryker Corp | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 58.614 $ | 0,72 | 186 | |
| Protagonist Therapeutics Inc | Protagonist Therapeutics Inc | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 57.403 $ | 0,70 | 580 | |
| Newamsterdam Pharma Co NV | Newamsterdam Pharma Co NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 55.521 $ | 0,68 | 1.944 | |
| Alumis Inc | Alumis Inc | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 53.898 $ | 0,66 | 2.183 | |
| Nuvalent Inc | Nuvalent Inc | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 52.146 $ | 0,64 | 520 | |
| Samsung Biologics Co Ltd | Samsung Biologics Co Ltd | EC | KR7207940008 | Long | Modellwert (Stufe 2) | beschränkt | 50.849 $ | 0,62 | 51 |
| Repligen Corp | Repligen Corp | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 50.282 $ | 0,62 | 425 | |
| IDEXX Laboratories Inc | IDEXX Laboratories Inc | EC | 45168D104 | Long | Börsenkurs (Stufe 1) | 49.911 $ | 0,61 | 89 | |
| Roivant Sciences Ltd | Roivant Sciences Ltd | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 41.397 $ | 0,51 | 1.451 | |
| Oruka Therapeutics Inc | Oruka Therapeutics Inc | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 41.251 $ | 0,51 | 603 | |
| Apogee Therapeutics Inc | Apogee Therapeutics Inc | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 40.367 $ | 0,50 | 487 | |
| Scholar Rock Holding Corp | Scholar Rock Holding Corp | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 38.313 $ | 0,47 | 822 | |
| RadNet Inc | RadNet Inc | EC | 750491102 | Long | Börsenkurs (Stufe 1) | 38.002 $ | 0,47 | 672 | |
| ORIC Pharmaceuticals Inc | ORIC Pharmaceuticals Inc | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 30.924 $ | 0,38 | 3.130 | |
| 7.996.792 $ | 98,17 | 88.071 |